Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

Effect of intravitreal injection of bevacizumab-chitosan nanoparticles on retina of diabetic rats.

Lu Y, Zhou N, Huang X, Cheng JW, Li FQ, Wei RL, Cai JP.

Int J Ophthalmol. 2014 Feb 18;7(1):1-7. doi: 10.3980/j.issn.2222-3959.2014.01.01. eCollection 2014.

2.

Effect of an intravitreal injection of bevacizumab on the expression of VEGF and CD34 in the retina of diabetic rats.

Ma J, Zhu T, Tang X, Ye P, Zhang Z.

Clin Exp Ophthalmol. 2010 Dec;38(9):875-84. doi: 10.1111/j.1442-9071.2010.02370.x.

PMID:
20653693
3.

Vitreous mediators after intravitreal bevacizumab or triamcinolone acetonide in eyes with proliferative diabetic retinopathy.

Arimura N, Otsuka H, Yamakiri K, Sonoda Y, Nakao S, Noda Y, Hashiguchi T, Maruyama I, Sakamoto T.

Ophthalmology. 2009 May;116(5):921-6. doi: 10.1016/j.ophtha.2008.12.024.

PMID:
19410951
4.
5.

Retinal function and morphology in rabbit after intravitreal injection of VEGF inhibitors.

Myers AC, Lövestam Adrian M, Bruun A, Ghosh F, Andréasson S, Ponjavic V.

Curr Eye Res. 2012 May;37(5):399-407. doi: 10.3109/02713683.2011.611609.

PMID:
22510009
6.

[The protective effect of pigment epithelial-derived factor modified human umbilical cord mesenchymal stem cells on rats with diabetic retinopathy].

Zhang W, Duan HT, Chen S, Wang YX, Kong JH, Dong M, Bi X, Song J.

Zhonghua Yan Ke Za Zhi. 2017 Jul 11;53(7):540-547. doi: 10.3760/cma.j.issn.0412-4081.2017.07.013. Chinese.

PMID:
28728289
7.

Anti-vascular endothelial growth factor for prevention of postoperative vitreous cavity haemorrhage after vitrectomy for proliferative diabetic retinopathy.

Smith JM, Steel DH.

Cochrane Database Syst Rev. 2015 Aug 7;(8):CD008214. doi: 10.1002/14651858.CD008214.pub3. Review.

PMID:
26250103
8.

Inhibitory effect of intravitreal injection of bevacizumab on nerve growth factor.

Jee D, Lee WK.

Curr Eye Res. 2012 May;37(5):408-15. doi: 10.3109/02713683.2011.632108. Epub 2011 Oct 31.

PMID:
22040304
9.

Angiofibrotic response to vascular endothelial growth factor inhibition in diabetic retinal detachment: report no. 1.

Sohn EH, He S, Kim LA, Salehi-Had H, Javaheri M, Spee C, Dustin L, Hinton DR, Eliott D.

Arch Ophthalmol. 2012 Sep;130(9):1127-34. doi: 10.1001/archophthalmol.2012.1611.

10.

Intravitreal anti-VEGF therapy blocks inflammatory cell infiltration and re-entry into the circulation in retinal angiogenesis.

Nakao S, Arima M, Ishikawa K, Kohno R, Kawahara S, Miyazaki M, Yoshida S, Enaida H, Hafezi-Moghadam A, Kono T, Ishibashi T.

Invest Ophthalmol Vis Sci. 2012 Jun 28;53(7):4323-8. doi: 10.1167/iovs.11-9119.

PMID:
22661475
12.

Effect of intravitreal bevacizumab on vascular endothelial growth factor expression in patients with proliferative diabetic retinopathy.

Chung EJ, Kang SJ, Koo JS, Choi YJ, Grossniklaus HE, Koh HJ.

Yonsei Med J. 2011 Jan;52(1):151-7. doi: 10.3349/ymj.2011.52.1.151.

13.

Vascular endothelial growth factor in plasma and vitreous fluid of patients with proliferative diabetic retinopathy patients after intravitreal injection of bevacizumab.

Ma Y, Zhang Y, Zhao T, Jiang YR.

Am J Ophthalmol. 2012 Feb;153(2):307-313.e2. doi: 10.1016/j.ajo.2011.08.006. Epub 2011 Oct 7.

PMID:
21982107
15.

Vascular endothelial growth factor in aqueous humor before and after intravitreal injection of bevacizumab in eyes with diabetic retinopathy.

Sawada O, Kawamura H, Kakinoki M, Sawada T, Ohji M.

Arch Ophthalmol. 2007 Oct;125(10):1363-6.

PMID:
17923544
16.
17.

Effect of multiple injections of small divided doses vs single injection of intravitreal bevacizumab on retinal neovascular model in rabbits.

Saati S, Agrawal RN, Louie S, Chader GJ, Humayun MS.

Graefes Arch Clin Exp Ophthalmol. 2010 Apr;248(4):457-66. doi: 10.1007/s00417-009-1153-z. Epub 2009 Jul 31.

18.

Succinate increases in the vitreous fluid of patients with active proliferative diabetic retinopathy.

Matsumoto M, Suzuma K, Maki T, Kinoshita H, Tsuiki E, Fujikawa A, Kitaoka T.

Am J Ophthalmol. 2012 May;153(5):896-902.e1. doi: 10.1016/j.ajo.2011.10.006. Epub 2012 Jan 20.

PMID:
22265145
19.

Effects of intravitreally injected bevacizumab on vascular endothelial growth factor in fellow eyes.

Matsuyama K, Ogata N, Matsuoka M, Wada M, Nishimura T, Takahashi K.

J Ocul Pharmacol Ther. 2011 Aug;27(4):379-83. doi: 10.1089/jop.2010.0194.

PMID:
21810018
20.

Intravitreal bevacizumab for surgical treatment of severe proliferative diabetic retinopathy.

di Lauro R, De Ruggiero P, di Lauro R, di Lauro MT, Romano MR.

Graefes Arch Clin Exp Ophthalmol. 2010 Jun;248(6):785-91. doi: 10.1007/s00417-010-1303-3. Epub 2010 Feb 5.

PMID:
20135139

Supplemental Content

Support Center